Cargando…

Screening strategies for pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is rare and, if untreated, has a median survival of 2–3 years. Pulmonary arterial hypertension may be idiopathic (IPAH) but is frequently associated with other conditions. Despite increased awareness, therapeutic advances, and improved outcomes, the time from sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiely, David G, Lawrie, Allan, Humbert, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915059/ https://www.ncbi.nlm.nih.gov/pubmed/31857796 http://dx.doi.org/10.1093/eurheartj/suz204

Ejemplares similares

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study
por: Rhodes, Christopher J, et al.
Publicado: (2017)

Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension
por: Rothman, Alexander M.K., et al.
Publicado: (2015)

Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future
por: Thompson, A. A. Roger, et al.
Publicado: (2020)

Risk assessment in pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2016)

Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension
por: Weatherald, Jason, et al.
Publicado: (2023)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2018)

Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
por: Boehm, Mario, et al.
Publicado: (2022)

The molecular targets of approved treatments for pulmonary arterial hypertension
por: Humbert, Marc, et al.
Publicado: (2016)

The role of combination therapy in managing pulmonary arterial hypertension
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2014)

Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study
por: Kheyfets, Vitaly O., et al.
Publicado: (2023)

Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension
por: McCullagh, Brian N., et al.
Publicado: (2015)

Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project
por: Bergemann, Rito, et al.
Publicado: (2018)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled
por: Hemnes, Anna R., et al.
Publicado: (2017)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Pulmonary arterial hypertension registries: past, present and into the future
por: Weatherald, Jason, et al.
Publicado: (2019)

Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension
por: Condliffe, Robin, et al.
Publicado: (2012)

Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Reversible pulmonary artery perfusion abnormalities in the postpartum period as a precursor to the development of pulmonary arterial hypertension
por: O’Riordan, Devaki, et al.
Publicado: (2018)

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
por: Humbert, Marc, et al.
Publicado: (2021)

Critical care outcome of pulmonary artery hypertension
por: Philips, A, et al.
Publicado: (2011)

Hospital burden of pulmonary arterial hypertension in France
por: Bergot, Emmanuel, et al.
Publicado: (2019)

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
por: Goh, Ze Ming, et al.
Publicado: (2022)

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
por: Rhodes, Christopher J., et al.
Publicado: (2020)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension
por: Lawrie, Allan, et al.
Publicado: (2022)

Arrhythmic Burden and Outcomes in Pulmonary Arterial Hypertension
por: Middleton, Jennifer T., et al.
Publicado: (2019)

A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis
por: Swift, Andrew J, et al.
Publicado: (2020)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
por: Masson, Bastien, et al.
Publicado: (2021)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
por: Perros, Frédéric, et al.
Publicado: (2021)

Circulating Protein Biomarkers in Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Review of Published Data
por: Hickey, Peter M., et al.
Publicado: (2018)

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
por: Guignabert, Christophe, et al.
Publicado: (2013)

New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension
por: Preston, Ioana R., et al.
Publicado: (2013)

Schistosomiasis-associated pulmonary arterial hypertension: a systematic review
por: Knafl, Daniela, et al.
Publicado: (2020)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ai9teqkpkcgo3t7lrv5pjg42bt